Home   >    Proteins   >   Signaling Proteins

GRB7 Protein

Recombinant full-length human GRB7 was expressed by E.coli using an N-terminal GST tag.
Catalog No. G45-30GG




Catalog No. Pack Size Price (USD)
G45-30GG-20 20 ug $215
G45-30GG-50 50 ug $435
G45-30GG-BULK BULK Contact Us  


Overview:

GRB7 or growth factor receptor-bound protein 7 belongs to a small family of adapter proteins which interact with a number of receptor tyrosine kinases and signaling molecules. GRB7 encodes a growth factor receptor-binding protein that interacts with epidermal growth factor receptor (EGFR) and ephrin receptors. GRB7 is highly expressed in liver and kidney (1). GRB7 isoforms are involved in cell invasion and metastatic progression of human esophageal carcinomas (2). GRB7 plays an important role in the integrin signaling pathway and cell migration by binding with focal adhesion kinase (FAK).


Gene Aliases:

B47


Genbank Number:


References:


1. Skolnik, E. Y. et.al: Cloning of PI3 kinase- associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65: 83-90, 1991.

2. Tanaka, S. et.al: A novel variant of human Grb7 is associated with invasive esophageal carcinoma. J. Clin. Invest. 102: 821-827, 1998.


Purity:

Sample Purity Data. For specific information on a given lot, see related technical data sheet.


Storage, Stability and Shipping:

Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.


Molecular Weight:

~91 kDa



Product Datasheets



There are no related publications available for this product.


RESEARCH AREAS

Angiogenesis, Apoptosis/Autophagy, Cancer, Cardiovascular Disease, ERK/MAPK Pathway, Invasion/Metastasis, JAK/STAT Pathway, Neurobiology


RELATED PRODUCTS


  GRB2 Protein, G45-30G


SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox